During the past decade, Infectious Disease Solutions conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Infectious Disease Solutions" are "HIV Infection" (1 trials) and "HIV Infections" (1 trials). Many other conditions were trialed in "Infectious Disease Solutions" in a lesser frequency.

Most popular intervention types in "Infectious Disease Solutions" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "abacavir (ABC)/lamivudine (3TC)" (1 trials) and "emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Infectious Disease Solutions" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Infectious Disease Solutions". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Infectious Disease Solutions, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Infectious Disease Solutions, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".